MacGregor E A
City of London Migraine Clinic, United Kingdom.
Neurol Clin. 1997 Feb;15(1):125-41. doi: 10.1016/s0733-8619(05)70299-1.
All women with migraine are susceptible to the effects of hormonal changes. For a minority with menstrual migraine, fluctuating hormones of the normal ovarian cycle are a specific trigger, particularly during perimenopause. The author proposes that the term menstrual migraine should be restricted to migraine attacks occurring on day 1 +/- 2 days of the menstrual cycle with freedom from migraine during the rest of the cycle. This definition is compatible with the mechanism of estrogen withdrawal. Other mechanisms such as prostaglandin release also may be important for some women. The changing hormonal environment at various stages of life provides further evidence of the role of estrogen in migraine. Treatments that stabilize hormone levels in the form of estrogen supplementation for menstrual migraine, elimination of the pill-free week, and adequate, stable levels of estrogen for HRT, all are associated with an improvement in migraine. The control of the menstrual cycle, however, is extremely complex, and until further studies are undertaken using strict criteria, the mechanism of migraine triggered by hormonal events remains uncertain.
所有偏头痛女性都易受激素变化的影响。对于少数患有经期偏头痛的女性,正常卵巢周期中波动的激素是一种特定的触发因素,尤其是在围绝经期。作者建议,经期偏头痛这一术语应仅限于在月经周期第1天±2天出现的偏头痛发作,且在周期的其余时间无偏头痛发作。这一定义与雌激素撤退机制相符。其他机制,如前列腺素释放,对一些女性可能也很重要。生命各阶段不断变化的激素环境进一步证明了雌激素在偏头痛中的作用。以补充雌激素治疗经期偏头痛、取消无药周以及为激素替代疗法维持足够稳定的雌激素水平等稳定激素水平的治疗方法,均与偏头痛症状改善相关。然而,月经周期的调控极为复杂,在采用严格标准进行进一步研究之前,激素事件引发偏头痛的机制仍不确定。